No matter how cynical the overall market is Aprea Therapeutics Inc. (APRE) performance over the last week is recorded 15.20%

Witnessing the stock’s movement on the chart, on February 11, 2021, Aprea Therapeutics Inc. (NASDAQ: APRE) had a quiet start as it plunged -9.82% to $7.35. During the day, the stock rose to $8.46 and sunk to $7.33 before settling in for the price of $8.15 at the close. Taking a more long-term approach, APRE posted a 52-week range of $4.66-$41.12.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Nevertheless, stock’s Earnings Per Share (EPS) this year is -64.90%. This publicly-traded company’s shares outstanding now amounts to $21.19 million, simultaneously with a float of $18.45 million. The organization now has a market capitalization sitting at $149.43 million. At the time of writing, stock’s 50-day Moving Average stood at $13.46, while the 200-day Moving Average is $24.54.

Aprea Therapeutics Inc. (APRE) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Aprea Therapeutics Inc.’s current insider ownership accounts for 12.91%, in contrast to 88.70% institutional ownership. According to the most recent insider trade that took place on Oct 05, this organization’s Former 10% holder sold 175,000 shares at the rate of 25.30, making the entire transaction reach 4,427,500 in total value, affecting insider ownership by 138,497. Preceding that transaction, on Jul 07, Company’s 10% Owner sold 241,703 for 34.55, making the whole transaction’s value amount to 8,350,839. This particular insider is now the holder of 1,992,586 in total.

Aprea Therapeutics Inc. (APRE) Earnings and Revenue Records

As on 9/29/2020, Multinational firm has announced its last quarter scores, in which it reported -$0.58 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.76) by $0.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.

Aprea Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -64.90% and is forecasted to reach -1.94 in the upcoming year.

Aprea Therapeutics Inc. (NASDAQ: APRE) Trading Performance Indicators

Let’s observe the current performance indicators for Aprea Therapeutics Inc. (APRE). It’s Quick Ratio in the last reported quarter now stands at 7.50. The Stock has managed to achieve an average true range (ATR) of 0.57.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!


In the same vein, APRE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.30, a figure that is expected to reach -0.64 in the next quarter, and analysts are predicting that it will be -1.94 at the market close of one year from today.

Technical Analysis of Aprea Therapeutics Inc. (APRE)

Going through the that latest performance of [Aprea Therapeutics Inc., APRE]. Its last 5-days volume of 2.5 million indicated improvement to the volume of 2.22 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 80.79% While, its Average True Range was 0.75.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Raw Stochastic average of Aprea Therapeutics Inc. (APRE) in the period of the previous 100 days is set at 10.22%, which indicates a major fall in contrast to 66.77% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 90.59% that was lower than 265.38% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.